Evidence map›Paper›PMID 21695078›Full record

ArticlePloS one2011

Enhanced virulence of Chlamydia muridarum respiratory infections in the absence of TLR2 activation.

Xianbao He, Anjali Nair, Samrawit Mekasha, Joseph Alroy, Catherine M O'Connell, Robin R Ingalls

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
2.6field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 26 citations in OpenAlex.

  1. Cervicovaginal microbial features predictInfection and immunity · 2025
    Article
  2. Veterinary pathology · 2024
    Article
  3. Plasmid-mediated virulence inFrontiers in cellular and infection microbiology · 2023
    Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 1 country.

Xianbao HeSection of Infectious Diseases, Boston Medical Center, Boston University School of Medicine, Boston, Massachusetts, United States of America.
Anjali Nair
Samrawit Mekasha
Joseph Alroy
Catherine M O'Connell
Robin R Ingalls
Boston Medical Center · USBoston University · USChildren's Hospital of Pittsburgh · USTufts Medical Center · US

Funding

Interaction of Chlamydia with Innate Immune ReceptorsR01AI064749 · NIAID · BOSTON MEDICAL CENTER · PI INGALLS, ROBIN R · 2005 to 2009
$1.5M
TLR2 ligands of chlamydiaeR21AI083657 · NIAID · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI O'CONNELL, CATHERINE MARY · 2009 to 2010
$417k
NIAID NIH HHS R01 AI064749NIAID NIH HHS R21 AI083657
6 · The paper itself

Abstract

Chlamydia trachomatis is a common sexually transmitted pathogen and is associated with infant pneumonia. Data from the female mouse model of genital tract chlamydia infection suggests a requirement for TLR2-dependent signaling in the induction of inflammation and oviduct pathology. We hypothesized that the role of TLR2 in moderating mucosal inflammation is site specific. In order to investigate this, we infected mice via the intranasal route with C. muridarum and observed that in the absence of TLR2 activation, mice had more severe disease, higher lung cytokine levels, and an exaggerated influx of neutrophils and T-cells into the lungs. This could not be explained by impaired bacterial clearance as TLR2-deficient mice cleared the infection similar to controls. These data suggest that TLR2 has an anti-inflammatory function in the lung during Chlamydia infection, and that the role of TLR2 in mucosal inflammation varies at different mucosal surfaces.

Indexed as

AnimalsChlamydia InfectionsChlamydia muridarumCytokinesFemaleGene Expression RegulationInflammationLungMacrophagesMaleMicePlasmidsRespiratory Tract InfectionsToll-Like Receptor 2CytokinesTlr2 protein, mouseToll-Like Receptor 2

Identifiers

PMID21695078
PMCPMC3114860
OpenAlexW2030416409

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.